Intranasal dexmedetomidine the night before surgery linked to lower postoperative delirium in older patients
A randomized trial of 232 older adults undergoing hip or knee surgery found that a single intranasal dose of dexmedetomidine (100 μg) given the night before surgery was associated with a 50% lower risk of postoperative delirium within 3 days compared to placebo.
Postoperative delirium—a common neurocognitive complication after surgery in older adults—affects cognition, awareness, and recovery. Poor preoperative sleep is a known risk factor.
Researchers in China tested whether intranasal dexmedetomidine, a sedative medication, given the night before surgery could reduce delirium risk. The trial enrolled 232 patients aged 60 and older scheduled for hip or knee replacement under general anesthesia and randomly assigned them to receive either 100 μg of intranasal dexmedetomidine or saline at 21:00 the night before surgery. Within 3 days after surgery, delirium occurred in 10.3% of the dexmedetomidine group versus 20.7% in placebo (relative risk = 0.50; 95% CI = 0.26–0.95; P = 0.030). The medication also appeared to improve sleep quality before and after surgery and reduce preoperative and postoperative anxiety and pain. No severe adverse events or nasal mucosal damage were reported in either group. The mechanism may involve improved preoperative sleep quality, though the trial does not establish causation. A single-center design and lack of long-term follow-up beyond 7 days limit the generalizability of findings.
The 50% relative risk reduction is substantial, but the absolute risk drop was 10.4 percentage points (from 20.7% to 10.3%), meaning about 10 of 100 high-risk older patients would avoid delirium with this intervention. Secondary outcomes showed dexmedetomidine improved perioperative sleep quality (measured but specific metrics not detailed in abstract), reduced both preoperative and postoperative anxiety, and lowered postoperative pain—all factors that independently influence delirium risk. The trial captured delirium up to 7 days postoperatively; in the full cohort, 7-day delirium incidence, duration, and severity are mentioned as measured but specific numbers were not reported in the excerpt provided, though the mechanism hypothesis centers on sleep restoration. Limitations include single-center design (generalizability unclear), lack of detail on which patients benefited most (older vs. younger within the 60+ range, ASA status differences), and no comparison to other delirium prevention strategies (cognitive pacing, early mobilization). The intranasal route avoids systemic absorption issues and was well tolerated, with no mucosal injury.
The deeper explanation, the effect sizes and caveats, and what this means for your own sleep, exercise and reading — read it inside Cadence.
Open in Cadence →References
- Effect of Intranasal Dexmedetomidine on the Night Before Surgery for Postoperative Delirium in Older Patients Undergoing Total Hip or Knee Arthroplasty: A Randomized Clinical Trial. — Drug design, development and therapy (Read the original)
- Wilson JE, Mart MF, Cunningham C, et al. Delirium.
- Aldecoa C, Bettelli G, Bilotta F, et al. Update of the European Society of Anaesthesiology and Intensive Care Medicine evidence-based and consensus-based guideline on postoperative delirium in adult p
- Swarbrick CJ, Partridge JSL. Evidence-based strategies to reduce the incidence of postoperative delirium: a narrative review.
- Neuman MD, Feng R, Carson JL, et al. Spinal Anesthesia or General Anesthesia for Hip Surgery in Older Adults.
- Li T, Li J, Yuan L, et al. Effect of Regional vs General Anesthesia on Incidence of Postoperative Delirium in Older Patients Undergoing Hip Fracture Surgery: the RAGA Randomized Trial.